#Cardiac Rhythm Management Devices Market

[wemresearch]

Cardiac rhythm management devices are battery powdered devices that are placed inside human body to help monitor and control heart rhythm. The most common type of cardiac rhythm management devices are implantable cardioverter defibrillators and pacemakers. 

[mrunalnerkarblog]

Cardiac Rhythm Management (CRM) devices include pacemakers (PMs), implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. These devices perform various functions, including bradycardia pacing, cardiac resynchronization for heart failure, monitoring for arrhythmias, defibrillation, and anti-tachycardia pacing for tachyarrhythmia. Products such as cardiac resynchronization therapy can improve congestive heart failure symptoms by improving the timing of the heart’s contractions, resulting in pumping more blood to the body.

[visionresearchreports]

The global Cardiac Rhythm Management Devices market size is expected to be worth around US$ 39.9 billion by 2030, according to a new report study.

The global Cardiac Rhythm Management Devices market size was valued at US$ 26.9 billion in 2020 and is anticipated to grow at a CAGR of 7.10% during forecast period 2021 to 2030.

[market-insider]

Implantable Cardiac Rhythm Management Devices Market Outlook, 2030

The global implantable cardiac rhythm management devices market size is expected to reach USD 28.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2022 to 2030. The increasing global geriatric population prone to CVD diseases and the demand for accurate and effective diagnostics of these diseases are the factors contributing to the growth of implantable cardiac rhythm management (CRM) devices.

Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Hectic schedules and busy lifestyles are major factors for hypertension among individuals. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Pacemakers are the most implanted devices for conduction disorders and sinus dysfunctions. CRT devices and ICDs are comparatively new and incorporate better technology than their older counterparts.

Gain deeper insights on the market and receive your free copy with TOC now @: Implantable Cardiac Rhythm Management Device Market Report

The COVID-19 pandemic adversely impacted the market, in particular the ICDs market, with dampened demand and sales during 2020. The sales improved as the hospitals resumed elective surgeries. However, the progression of COVID-19 in several key markets continued to create uncertainty during the year. Abbott, for instance, reported improvement in its hospital-based businesses during Q2 and Q3 2020. However, the improving trends flattened or were negatively impacted during Q4 2020 due to a sudden increase in COVID-19 cases and hospitalizations in many countries. Nihon Kohden, on the other hand, reported strong sales growth of defibrillators in 2020, despite inhibited sales activity due to the pandemic.

Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Implanted pacemakers are majorly used for conduction disorders and sinus dysfunctions.

[markettrend24]

Cardiac Monitoring & Cardiac Rhythm Management Devices Market risks and challenges that the industry is facing

Cardiac Monitoring & Cardiac Rhythm Management Devices Market risks and challenges that the industry is facing

The Cardiac Monitoring & Cardiac Rhythm Management Devices Market research report 2022-2030 provides an in-depth analysis of the changing trends, opportunities, and challenges influencing the growth over the next decade. The study includes a detailed summary of each market along with data related to demand, supply and distribution. The report examines Cardiac Monitoring & Cardiac Rhythm…

[desaletushki]

Cardiac Rhythm Management Devices Market Growth USD31.9 Billion By 2030

The global cardiac rhythm management devices market size is anticipated to reach USD 31.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 6.5% from 2022 to 2030. The key factors driving the market include growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the Centers for Disease Control and Prevention (CDC), as of September 2021, approximately 659,000 Americans die suffering from heart disease every year. The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic.

Major players in the market such as Medtronic; Abbott; and Boston Scientific Corporation, incurred huge losses in their cardiac rhythm management business segments globally. This resulted in negative growth of the market in 2020. The rising demand for handling sudden cardiac arrests is leading to innovation in all types of cardiac rhythm management devices. Innovation with regards to implantable devices includes products, such as subcutaneous and transvenous devices, that aim to increase the comfort level of patients. Swedish Transport Agency ran a program under the test phase, which aimed to deliver AEDs using a drone. This may reduce the delivery time of an AED, increasing the chances of survival with faster treatment.

Therefore, the market is anticipated to grow because of technological advancements and product innovations. Revolutionary technological signs of progress are rapidly transforming the market. These expansions are producing lucrative potentials. An increase in R&D expenditure and new product launches by leading firms further fueled the growth. For instance, in October 2020, Abbott launched its new ICD and CRT-D in India, hence expanding its product portfolio in the country. The company had also received CE Mark approval for its Gallant ICD and CRT-D devices in February 2020. Such factors boost market growth. Key market players account for a significant share of the market owing to their extensive product offerings.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/cardiac-rhythm-management-devices-industry

Cardiac Rhythm Management Devices Market Report Growth And Trends

The market was valued at USD 18.1 million in 2021 and is expected to expand at a CAGR of 6.5% during the forecast period

By product, defibrillators dominated the market with a share of over 43.6% in 2021 due to their high adoption globally

The ICD segment was the largest in defibrillators as of 2021, accounting for more than 60% of the revenue share, owing to its better patient outcome

In the external defibrillator segment, the automatic external defibrillator segment held the highest revenue share owing to associated benefits, including pacing, i.e., delivering pulses of the current to stimulate heart contraction as well as cardioversion, converting arrhythmia or tachycardia to a normal heartbeat

In 2021, North America held the dominant share of the market owing to the rising prevalence of cardiovascular diseases and high adoption of CRM devices

Asia Pacific region is expected to show lucrative growth over the forecast period owing to the presence of emerging countries such as China and India 

Cardiac Rhythm Management Devices Market Share Insights

The industry is marked by the presence of various large and small business operators. It is competitive and dominated by participants such as Medtronic, Abbott, Boston Scientific Corporation, and Koninklijke Philips N.V. Key players are focusing on executing innovative strategies like mergers and acquisitions, market penetration, partnerships, and distribution agreements to intensify their revenue. For instance, in July 2020, Abbott received the U.S. Food and Drug Administration (FDA) clearance for its Gallant ICD and CRT-D devices. This enabled the company to market the device in the U.S. while expanding its portfolio. Some of the prominent players in the cardiac rhythm management devices market include: Physio-Control Inc. (Stryker), Schiller, Medtronic, Abbott, Boston Scientific Corporation, Koninklijke Philips N.V., Zoll Medical Corporation, BIOTRONIK, Progetti Srl, LivaNova Plc

Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/cardiac-rhythm-management-devices-industry

[meditech-insights]

Cardiac Rhythm Management (CRM) Devices Market: Competitive Landscape and Key Product to 2026

A technique involving implantation of a device in the upper chest and connected to the heart to control both fast and slow heart rhythms by using electrical pulses is called as cardiac rhythm management (CRM), and the device is called as cardiac rhythm management device. CRM devices execute numerous functions, such as arrhythmias monitoring, cardiac resynchronization for heart failure, bradycardia pacing, defibrillation and anti-tachycardia pacing for tachyarrhythmias.

The Global Cardiac Rhythm Management (CRM) Devices Market valued at $10.8 billion (2021) is set to witness a growth rate of 8% in the next 5 years. Rising occurrence of cardiovascular diseases (CVDs), increasing geriatric population prone to CVDs, development of technologically advanced products, and growing adoption of sedentary lifestyle among general population are some of the key factors driving the Global Cardiac Rhythm Management (CRM) Devices Market.

Technological advancements in CRM devices to fuel its Cardiac Rhythm Management (CRM) Devices Market demand

Continuous advances in CRM have enabled to develop efficient devices with increased battery longevity, smaller size, Bluetooth enabled, and MRI-compatible, among others. Such advancements tend to provide competitive edge to manufacturers and therefore, major players are continuously focusing on new product development to strengthen their positions in cardiac rhythm management (CRM) devices market. Some of the technological advancements are listed below:

In May 2022, MicroPort CRM received approval from China’s National Medical Products Administration (NMPA) for its Platinium implantable cardioverter defibrillator (ICD), with an expected lifespan of 13-14 years reducing the risks associated with frequent replacements

In April 2022, Abbott’s Aveir single-chamber (VR) leadless pacemaker has received the U.S. Food and Drug Administration (FDA) approval for the treatment of patients with slow heart rhythms in the U.S.

In January 2022, Medtronic plc received approval from Ministry of Health, Labor and Welfare, Japan to sell and reimburse its Micra AV Transcatheter Pacing System (TPS), one of the world’s smallest pacemakers

In July 2020, Abbott received the U.S. Food and Drug Administration (FDA) approval for its Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices that offer MRI compatibility and increased battery longevity

Explore Premium Report on Cardiac Rhythm Management (CRM) Devices Market @ https://meditechinsights.com/cardiac-rhythm-management-devices-market/

Increasing prevalence of cardiovascular diseases (CVDs) to boost adoption of Cardiac Rhythm Management (CRM) Devices Market

Cardiovascular diseases are one of the foremost causes of death across the globe. Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other illnesses are among the group of heart and blood vessel disorders known as CVDs. Heart attacks and strokes account for more than four out of every five deaths caused by CVDs, and one third of these deaths happen before the age of 70.   

According to WHO, 32% of all deaths across the globe i.e., 17.9 million people die due to CVD every year

As per CDC,

o   659,000 people in the US die from heart disease every year; heart diseases costs $363 billion each year in the US which includes cost of medicines and healthcare services

o   Coronary heart disease alone killed 360,900 people in 2019 in the US and over 18.2 million adults suffering from coronary artery disease live in the US

   According to European Heart Network, CVDs account for over 3.9 million deaths every year in the European region, out of which over 1.8 million deaths occur in the European Union (EU)

      In 2019, the mortality rate of CVDs in China was 364.5 per 100,000 population

Furthermore, rising geriatric population prone to heart defects due to progressive deterioration in the structure and function of the heart, largely contributes to the high burden of CVDs; thereby triggering the increased adoption of CRM devices.

Competitive Landscape Analysis of Cardiac Rhythm Management (CRM) Devices Market

The global cardiac rhythm management (CRM) devices market is marked by the presence of key players such as Medtronic (Ireland); Boston Scientific Corporation (US); Abbott Laboratories (US); BIOTRONIK SE & Co. KG (Germany); Stryker Corporation (US); Koninklijke Philips N.V. (Netherlands); and others.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

[sumit12-blog]

Understanding Pacemaker Necessity: Insights from Dr. Md. Farhan Shikoh, Ranchi's Leading Cardiologist

Dr. Md. Farhan Shikoh, recognized as the Best Cardiologist in Ranchi, practices at Sukoon Heart Care located at Sainik Market, Main Road, Ranchi, Jharkhand, 834001. With qualifications including MBBS, MD (Medicine), and DM (Cardiology), Dr. Shikoh specializes in providing expert care and guidance on various cardiac conditions.

Dr. Shikoh emphasizes the importance of recognizing signs that may indicate a need for a pacemaker, a small device used to control abnormal heart rhythms. Common indications that patients might benefit from a pacemaker include:

Bradycardia: Symptoms such as dizziness, fainting, shortness of breath, or fatigue due to a slow heartbeat.

Heart Block: Disruption in the heart's electrical signals leading to symptoms like fatigue, fainting, chest pain, or shortness of breath.

Syncope: Sudden loss of consciousness or fainting, which can be caused by abnormal heart rhythms.

Atrial Fibrillation with Bradycardia: Irregular heartbeat accompanied by slow heart rate episodes.

Dr. Shikoh urges individuals experiencing these symptoms to seek medical advice promptly to assess if a pacemaker could be beneficial. Early intervention not only improves quality of life but also reduces the risk of serious complications.

Patients seeking consultation with the Best Cardiologist in Ranchi can contact Dr. Farhan Shikoh at 6200784486 or visit his website, drfarhancardiologist.com. At Sukoon Heart Care, Dr. Shikoh and his team provide personalized cardiac care with a focus on patient well-being and comprehensive treatment plans tailored to individual needs.

Understanding the signs indicating a potential need for a pacemaker is crucial for timely intervention and effective management of heart health. Dr. Md. Farhan Shikoh's commitment to excellence in cardiology ensures that patients receive the highest standard of care for their cardiac concerns.

[lifesciencemarketresearch]

The Global Cardiovascular Devices Market: Key Insights and Future Projections

The cardiovascular devices market is a dynamic and rapidly evolving sector within the broader medical technology field. In LSI’s Market Intelligence platform, our analysts segment the global cardiovascular devices market into five major categories: rhythm management, transcatheter technologies, electrophysiology, neurovascular devices, and cardiac surgery. Innovation in each segment plays a crucial role in advancing cardiovascular health and offering solutions for a range of conditions. Leveraging LSI’s most recent market data, our analysts explored the current state and future projections for this market. This content is originally published here: https://www.lifesciencemarketresearch.com/insights/the-global-cardiovascular-devices-market-key-insights-and-future-projections

[wemresearch]

[mrunalnerkarblog]

Cardiac Rhythm Management (CRM) devices include pacemakers (PMs), implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. These devices perform various functions, including bradycardia pacing, cardiac resynchronization for heart failure, monitoring for arrhythmias, defibrillation, and anti-tachycardia pacing for tachyarrhythmia. Products such as cardiac resynchronization therapy can improve congestive heart failure symptoms by improving the timing of the heart’s contractions, resulting in pumping more blood to the body.

[home-basedpoint]

In recent years, the landscape of healthcare delivery has undergone a profound transformation with the advent of home-based point of care (POC) solutions. These innovative technologies empower individuals to monitor their health conditions conveniently from the comfort of their homes, marking a paradigm shift in how healthcare services are accessed and delivered. As the demand for personalized and convenient healthcare solutions continues to rise, the home-based POC market has emerged as a promising frontier, offering significant opportunities for both patients and healthcare providers.

Home-based POC devices encompass a diverse range of medical technologies designed to enable rapid and accurate diagnostic testing, monitoring, and treatment outside traditional clinical settings. From glucose monitoring systems for diabetic patients to portable ultrasound devices for prenatal care, these tools empower individuals to take control of their health and manage chronic conditions effectively. The market for home-based POC solutions is witnessing rapid growth, driven by factors such as the aging population, increasing prevalence of chronic diseases, and advancements in technology.

One of the key drivers fueling the expansion of the home-based POC market is the growing preference for patient-centric care models. With an emphasis on preventive care and early intervention, healthcare providers are increasingly recognizing the importance of empowering patients to actively participate in managing their health. Home-based POC devices enable real-time monitoring of vital signs and biomarkers, allowing for timely interventions and adjustments to treatment plans. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with hospital readmissions and complications.

Moreover, the COVID-19 pandemic has accelerated the adoption of home-based POC solutions as healthcare systems seek alternatives to traditional in-person consultations. Telemedicine platforms combined with remote monitoring devices have become invaluable tools for delivering virtual care, ensuring continuity of medical services while minimizing the risk of exposure to infectious diseases. Patients can consult with healthcare providers remotely and transmit vital health data in real-time, facilitating timely diagnosis and treatment decisions

For a comprehensive analysis of the market drivers:-https://univdatos.com/report/home-based-point-of-care-market/

The home-based POC market is characterized by a diverse array of products catering to various medical specialties and conditions. For instance, blood glucose meters, insulin pumps, and continuous glucose monitoring systems are indispensable tools for diabetic patients, enabling them to monitor blood sugar levels and adjust insulin dosages as needed. Similarly, cardiac monitoring devices offer non-invasive means of tracking heart rhythm abnormalities, providing early warning signs of cardiovascular events.

In addition to chronic disease management, home-based POC solutions are also proving instrumental in enhancing maternal and fetal health outcomes. Portable fetal dopplers and home ultrasound devices enable expectant mothers to monitor the well-being of their unborn babies from the comfort of their homes, reducing the need for frequent clinic visits. These technologies empower women to take a proactive role in their prenatal care, fostering greater peace of mind and reassurance throughout the pregnancy journey.

 However, the widespread adoption of home-based POC devices is not without challenges. Data security and privacy concerns remain paramount, particularly given the sensitive nature of health information transmitted through these devices. Ensuring compliance with regulatory standards and safeguarding patient data against breaches and unauthorized access are critical priorities for stakeholders in the home-based POC market.

For a sample report, visit:- https://univdatos.com/get-a-free-sample-form-php/?product_id=4974 

Furthermore, disparities in access to technology and digital literacy pose barriers to adoption, particularly among underserved populations and elderly individuals. Addressing these disparities requires targeted interventions to improve digital health literacy and expand access to affordable POC devices among vulnerable communities.

In conclusion, the home-based point of care market represents a dynamic and rapidly evolving segment of the healthcare industry, offering transformative benefits for patients, providers, and healthcare systems alike. By leveraging the power of technology to bring healthcare services directly to the homes of individuals, these innovative solutions have the potential to revolutionize the way healthcare is delivered, enhancing convenience, efficiency, and patient outcomes in the process. As the market continues to expand and mature, collaboration among stakeholders will be essential to overcome challenges and unlock the full potential of home-based POC solutions in improving global health outcomes.

Home-based point of care acceptance moved the delivery of healthcare from an office to the patient’s home as it provides patient-centered care at their homes. Home-based point of care are used as an alternative way for organizing and delivering care that may better address the needs, values, and preferences of chronically ill, fragile, and physically or cognitively disabled patients who have difficulty in accessing office-based primary care or other models of care that require office visits. According to the Home Healthcare News in 2020, the Medical Advantage plans cover non-medical, in-home support, and services. The flourishing new opportunity for home-based point of care providers to participate in Medical Advantage, serves 34% of all Medicare beneficiaries, with 22 million total enrollees. This shows the interest of other medical organizations in the home-based point of care market. Also, Amazon in march 2021, reveals their national expansion plans of an in-home care platform called “Amazon Care” which will provide on-demand health care service at patient’s homes.

Moreover, increasing technological advancement like remote patient monitoring and telehealth in home-based point of care services is likely to be a factor for the tremendous growth of the market. Also, the healthcare cost curve and excessive health expenditure have been reduced due to home-based point of care services. As, the researchers at the “Cleveland Clinic” in the United States determined that the use of home-based point of care services following inpatient care decreased the number of follow-ups, and hospital readmissions, saving nearly USD 6,500 per patient over a year. Likewise, according to the Centers for Medicare & Medicaid Services (CMS) in 2020, estimates that the home health care in Medicare saves at least USD 378 million a year through diminished hospitalizations, based on the nine states participating in the Home Health Value-Based Purchasing (HHVBP). Value-based care arrangements link quality, outcomes, safety, and other measures directly to reimbursements. This demand for patient-centric healthcare services at homes, in return, increases the requirement for healthcare workers and agencies and is anticipated as a driving factor for the market growth.

Contact Us: UnivDatos Market Insights Email - contact@univdatos.com  Contact Number - +1 9782263411 Website -www.univdatos.com